Dr. Reddy’s Laboratories Ltd ADR (RDY) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NYSE

Key Metrics

• Price: $14.57
• Market Cap: $12.26B
• P/E Ratio: 19.47
• EPS: $0.75
• 52-Week High: $16.07
• 52-Week Low: $12.18

Market Sentiment

Dr. Reddy’s Laboratories Ltd ADR currently has a Bullish sentiment score of 0.33.

About Dr. Reddy’s Laboratories Ltd ADR

Dr. Reddy's Laboratories Ltd (ADR) is a leading global pharmaceutical company based in Hyderabad, India, known for its comprehensive portfolio of generic medicines, proprietary drugs, and active pharmaceutical ingredients. With a strong focus on research and development, Dr. Reddy's fosters innovation across various therapeutic segments while maintaining a robust supply chain to serve markets worldwide. The company's commitment to providing high-quality, affordable healthcare solutions underl...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Dr. Reddy’s Laboratories Ltd ADR and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does RDY pay dividends?

Dr. Reddy’s Laboratories Ltd ADR (RDY) does not currently pay a regular dividend.

What is RDY's P/E ratio?

Dr. Reddy’s Laboratories Ltd ADR has a price-to-earnings (P/E) ratio of 19.47.

What is RDY's market cap?

Dr. Reddy’s Laboratories Ltd ADR (RDY) has a market capitalization of $12.26B with a current stock price of $14.57.